Aemetis (AMTX) Competitors

$2.32 +0.11 (+4.75%)

As of 01:30 PM Eastern

AMTX vs. WLKP, ASIX, ASPI, ADUR, and OEC

Should you buy Aemetis stock or one of its competitors? MarketBeat compares Aemetis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aemetis include Westlake Chemical Partners (WLKP), AdvanSix (ASIX), ASP Isotopes (ASPI), Aduro Clean Technologies (ADUR), and Orion (OEC). These companies are all part of the "chemicals" industry.

How does Aemetis compare to Westlake Chemical Partners?

Westlake Chemical Partners (NYSE:WLKP) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, media sentiment, profitability and analyst recommendations.

Westlake Chemical Partners has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than Westlake Chemical Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Westlake Chemical Partners	$1.23B	0.66	$48.70M	$1.64	14.12
Aemetis	$219.71M	0.74	-$77M	-$1.19	N/A

Aemetis has a consensus price target of $8.58, suggesting a potential upside of 269.18%. Given Aemetis' stronger consensus rating and higher possible upside, analysts plainly believe Aemetis is more favorable than Westlake Chemical Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Westlake Chemical Partners	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Westlake Chemical Partners has a net margin of 4.69% compared to Aemetis' net margin of -35.43%. Westlake Chemical Partners' return on equity of 7.15% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Westlake Chemical Partners	4.69%	7.15%	4.57%
Aemetis	-35.43%	N/A	-33.44%

In the previous week, Aemetis had 14 more articles in the media than Westlake Chemical Partners. MarketBeat recorded 14 mentions for Aemetis and 0 mentions for Westlake Chemical Partners. Westlake Chemical Partners' average media sentiment score of 0.00 beat Aemetis' score of -0.01 indicating that Westlake Chemical Partners is being referred to more favorably in the media.

Company	Overall Sentiment
Westlake Chemical Partners	Neutral
Aemetis	Neutral

78.3% of Westlake Chemical Partners shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 1.1% of Westlake Chemical Partners shares are held by company insiders. Comparatively, 13.0% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Westlake Chemical Partners has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Summary

Westlake Chemical Partners beats Aemetis on 9 of the 16 factors compared between the two stocks.

How does Aemetis compare to AdvanSix?

Aemetis (NASDAQ:AMTX) and AdvanSix (NYSE:ASIX) are both small-cap chemicals companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Aemetis has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, AdvanSix has a beta of 1.33, indicating that its share price is 33% more volatile than the broader market.

27.0% of Aemetis shares are owned by institutional investors. Comparatively, 86.4% of AdvanSix shares are owned by institutional investors. 13.0% of Aemetis shares are owned by insiders. Comparatively, 5.0% of AdvanSix shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

AdvanSix has a net margin of 0.67% compared to Aemetis' net margin of -35.43%. AdvanSix's return on equity of 2.18% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aemetis	-35.43%	N/A	-33.44%
AdvanSix	0.67%	2.18%	1.05%

Aemetis currently has a consensus price target of $8.58, indicating a potential upside of 269.18%. AdvanSix has a consensus price target of $25.67, indicating a potential upside of 16.01%. Given Aemetis' stronger consensus rating and higher probable upside, research analysts clearly believe Aemetis is more favorable than AdvanSix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
AdvanSix	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, AdvanSix had 3 more articles in the media than Aemetis. MarketBeat recorded 17 mentions for AdvanSix and 14 mentions for Aemetis. AdvanSix's average media sentiment score of 0.12 beat Aemetis' score of -0.01 indicating that AdvanSix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aemetis	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdvanSix	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

AdvanSix has higher revenue and earnings than Aemetis. Aemetis is trading at a lower price-to-earnings ratio than AdvanSix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aemetis	$219.71M	0.74	-$77M	-$1.19	N/A
AdvanSix	$1.55B	0.39	$49.29M	$0.37	59.80

Summary

AdvanSix beats Aemetis on 10 of the 16 factors compared between the two stocks.

How does Aemetis compare to ASP Isotopes?

ASP Isotopes (NASDAQ:ASPI) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

ASP Isotopes has a beta of 3.26, indicating that its stock price is 226% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

In the previous week, Aemetis had 8 more articles in the media than ASP Isotopes. MarketBeat recorded 14 mentions for Aemetis and 6 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 0.47 beat Aemetis' score of -0.01 indicating that ASP Isotopes is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aemetis	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aemetis has a net margin of -35.43% compared to ASP Isotopes' net margin of -734.14%. Aemetis' return on equity of 0.00% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-734.14%	-161.55%	-73.67%
Aemetis	-35.43%	N/A	-33.44%

Aemetis has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	32.91	-$175.09M	-$2.14	N/A
Aemetis	$219.71M	0.74	-$77M	-$1.19	N/A

ASP Isotopes currently has a consensus price target of $13.00, indicating a potential upside of 108.50%. Aemetis has a consensus price target of $8.58, indicating a potential upside of 269.18%. Given Aemetis' higher possible upside, analysts plainly believe Aemetis is more favorable than ASP Isotopes.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by company insiders. Comparatively, 13.0% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Aemetis beats ASP Isotopes on 10 of the 14 factors compared between the two stocks.

How does Aemetis compare to Aduro Clean Technologies?

Aduro Clean Technologies (NASDAQ:ADUR) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Aduro Clean Technologies has a beta of 3.15, indicating that its share price is 215% more volatile than the broader market. Comparatively, Aemetis has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market.

In the previous week, Aemetis had 9 more articles in the media than Aduro Clean Technologies. MarketBeat recorded 14 mentions for Aemetis and 5 mentions for Aduro Clean Technologies. Aduro Clean Technologies' average media sentiment score of 1.19 beat Aemetis' score of -0.01 indicating that Aduro Clean Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aduro Clean Technologies	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aemetis	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aemetis has a net margin of -35.43% compared to Aduro Clean Technologies' net margin of -6,393.09%. Aemetis' return on equity of 0.00% beat Aduro Clean Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aduro Clean Technologies	-6,393.09%	-85.29%	-70.27%
Aemetis	-35.43%	N/A	-33.44%

Aduro Clean Technologies has higher earnings, but lower revenue than Aemetis. Aduro Clean Technologies is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aduro Clean Technologies	$170K	2,562.11	-$8.70M	-$0.44	N/A
Aemetis	$219.71M	0.74	-$77M	-$1.19	N/A

Aduro Clean Technologies presently has a consensus price target of $29.00, indicating a potential upside of 103.94%. Aemetis has a consensus price target of $8.58, indicating a potential upside of 269.18%. Given Aemetis' higher probable upside, analysts clearly believe Aemetis is more favorable than Aduro Clean Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aduro Clean Technologies	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

27.0% of Aemetis shares are held by institutional investors. 13.0% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Aemetis beats Aduro Clean Technologies on 9 of the 16 factors compared between the two stocks.

How does Aemetis compare to Orion?

Orion (NYSE:OEC) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

Orion has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market. Comparatively, Aemetis has a beta of 1.46, indicating that its stock price is 46% more volatile than the broader market.

94.3% of Orion shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 3.1% of Orion shares are owned by insiders. Comparatively, 13.0% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Aemetis had 9 more articles in the media than Orion. MarketBeat recorded 14 mentions for Aemetis and 5 mentions for Orion. Orion's average media sentiment score of 0.41 beat Aemetis' score of -0.01 indicating that Orion is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orion	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aemetis	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Orion has a net margin of -4.98% compared to Aemetis' net margin of -35.43%. Orion's return on equity of 2.23% beat Aemetis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orion	-4.98%	2.23%	0.47%
Aemetis	-35.43%	N/A	-33.44%

Orion has higher revenue and earnings than Aemetis. Orion is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orion	$1.79B	0.22	-$70.10M	-$1.60	N/A
Aemetis	$219.71M	0.74	-$77M	-$1.19	N/A

Orion presently has a consensus price target of $5.92, indicating a potential downside of 16.97%. Aemetis has a consensus price target of $8.58, indicating a potential upside of 269.18%. Given Aemetis' stronger consensus rating and higher probable upside, analysts clearly believe Aemetis is more favorable than Orion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orion	3 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.40
Aemetis	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Aemetis beats Orion on 9 of the 16 factors compared between the two stocks.

Get Aemetis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMTX vs. The Competition

Export

Metric	Aemetis	Biofuels Industry	Energy Sector	NASDAQ Exchange
Market Cap	$163.60M	$329.48M	$10.52B	$12.47B
Dividend Yield	N/A	5.90%	10.22%	5.30%
P/E Ratio	-1.95	3.92	20.39	25.60
Price / Sales	0.74	1.36	1,033.25	75.06
Price / Cash	N/A	15.32	37.93	55.34
Price / Book	-0.51	1.21	4.40	6.71
Net Income	-$77M	-$58.67M	$4.24B	$333.62M
7 Day Performance	-25.48%	-12.33%	1.40%	0.32%
1 Month Performance	1.97%	-6.32%	4.51%	4.06%
1 Year Performance	50.00%	20.37%	52.05%	36.29%

Aemetis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMTX Aemetis	2.4297 of 5 stars	$2.32 +4.8%	$8.58 +270.8%	+46.4%	$164.31M	$219.71M	N/A	160	Earnings Report Analyst Revision Gap Down
WLKP Westlake Chemical Partners	1.5348 of 5 stars	$22.95 -0.2%	N/A	+2.5%	$810.31M	$1.17B	16.63	150
ASIX AdvanSix	3.7979 of 5 stars	$25.43 +0.2%	$25.67 +0.9%	-6.5%	$683.95M	$1.52B	14.05	1,410	Earnings Report Dividend Announcement Analyst Upgrade
ASPI ASP Isotopes	2.2516 of 5 stars	$5.16 +0.2%	$13.00 +151.9%	-3.7%	$648.40M	$23.85M	N/A	76	Upcoming Earnings
ADUR Aduro Clean Technologies	2.6608 of 5 stars	$13.73 -4.7%	$29.00 +111.2%	+108.3%	$441.40M	$170K	N/A	N/A

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AMTX) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aemetis (AMTX) Competitors

AMTX vs. WLKP, ASIX, ASPI, ADUR, and OEC

How does Aemetis compare to Westlake Chemical Partners?

Summary

How does Aemetis compare to AdvanSix?

Summary

How does Aemetis compare to ASP Isotopes?

Summary

How does Aemetis compare to Aduro Clean Technologies?

Summary

How does Aemetis compare to Orion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMTX vs. The Competition

Aemetis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aemetis (AMTX) Competitors

AMTX vs. WLKP, ASIX, ASPI, ADUR, and OEC

How does Aemetis compare to Westlake Chemical Partners?

Which has higher valuation & earnings, WLKP or AMTX?

Do analysts recommend WLKP or AMTX?

Is WLKP or AMTX more profitable?

Does the media refer more to WLKP or AMTX?

Do institutionals and insiders believe in WLKP or AMTX?

Which has more volatility and risk, WLKP or AMTX?

Summary

How does Aemetis compare to AdvanSix?

Which has more volatility and risk, AMTX or ASIX?

Do institutionals & insiders believe in AMTX or ASIX?

Is AMTX or ASIX more profitable?

Do analysts recommend AMTX or ASIX?

Does the media prefer AMTX or ASIX?

Which has stronger earnings & valuation, AMTX or ASIX?

Summary

How does Aemetis compare to ASP Isotopes?

Which has more volatility and risk, ASPI or AMTX?

Does the media refer more to ASPI or AMTX?

Is ASPI or AMTX more profitable?

Which has preferable earnings & valuation, ASPI or AMTX?

Do analysts prefer ASPI or AMTX?

Do insiders and institutionals have more ownership in ASPI or AMTX?

Summary

How does Aemetis compare to Aduro Clean Technologies?

Which has more risk and volatility, ADUR or AMTX?

Does the media refer more to ADUR or AMTX?

Is ADUR or AMTX more profitable?

Which has better valuation and earnings, ADUR or AMTX?

Do analysts rate ADUR or AMTX?

Do institutionals and insiders have more ownership in ADUR or AMTX?

Summary

How does Aemetis compare to Orion?

Which has more volatility & risk, OEC or AMTX?

Do insiders & institutionals have more ownership in OEC or AMTX?

Does the media refer more to OEC or AMTX?

Is OEC or AMTX more profitable?

Which has preferable valuation & earnings, OEC or AMTX?

Do analysts rate OEC or AMTX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMTX vs. The Competition

Aemetis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools